Loredan S. Niculescu

Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5

Jamila Fruchart‐Najib, Eric Baugé, Loredan S. Niculescu et al. · Biochemical and Biophysical Research Communications · 2004 · 196 citations · Full text

Metabolic Syndrome, Human Apolipoprotein A5, Biochemistry +12

MiR-486 and miR-92a Identified in Circulating HDL Discriminate between Stable and Vulnerable Coronary Artery Disease Patients

Loredan S. Niculescu, N Simiónescu, Gabriela M. Sanda et al. · PLoS ONE · 2015 · 147 citations · Full text

Vascular Disease, Unstable Angina, Pathology +19

Dysfunctional high-density lipoproteins have distinct composition, diminished anti-inflammatory potential and discriminate acute coronary syndrome from stable coronary artery disease patients

Mihaela G. Carnuta, Camelia S. Stancu, Laura Toma et al. · Scientific Reports · 2017 · 60 citations · Full text

Analysis of circulating microRNAs that are specifically increased in hyperlipidemic and/or hyperglycemic sera

N Simiónescu, Loredan S. Niculescu, Gabriela M. Sanda et al. · Molecular Biology Reports · 2014 · 44 citations

Metabolic Syndrome, Engineering, Medicine +12

Caffeic acid attenuates the inflammatory stress induced by glycated LDL in human endothelial cells by mechanisms involving inhibition of AGE‐receptor, oxidative, and endoplasmic reticulum stress

Laura Toma, Gabriela M. Sanda, Loredan S. Niculescu et al. · BioFactors · 2017 · 42 citations